HealthInvestor Asia Summit 2018
Financial intelligence for Asia's healthcare markets
Remember me:

Analysis: Asia’s healthcare goldmine

Sumit Sharma, head of health & life sciences, Asia Pacific, at Oliver Wyman and Matt Zafra, engagement manager, health & life sciences, Oliver Wyman, look at the four themes that are going to dominate healthcare this year.

There is an ongoing shake-up in healthcare in the US, as incumbents react to an ever-shifting target of healthcare reform, while also reaching across to link up even greater parts of the value chain in new and interesting ways. In Asia, we have the opportunity to watch and learn as these big shifts and experiments fail, and others succeed.

At the same time, we are sitting on a latent goldmine. Asia has more than half of the world’s population and a wide range of diverse healthcare systems ripe for experimentation. The region has homegrown players that are, we think, more integrated and more nimble at the start than the best from the West (Alibaba versus Amazon), and rather than wait and see, there is an even better opportunity to test and learn.

Here are some of our healthcare predictions for 2018:

Progressing Universal Healthcare – From Fairy Tale to Reality

Much of the global spotlight on healthcare reform last year focused on Obamacare: repeal, replace, or remain? In Asia, however, universal healthcare is quietly but steadily moving ahead. Earlier this decade, Indonesia’s launch of its national healthcare programme, Jaminan Kesehatan Nasional (JKN), unfolded like a drama full of promises, rhetoric, and uncertainty about the future. While there have been implementation challenges, JKN has come a long way since then and seems to be more steady. Similarly, India recently announced an ambitious healthcare plan to cover half a billion people with low cost insurance. Universal coverage in large, emerging markets fuels overall industry growth and leads both to increased healthcare consumption and private sector participation. But it also impacts individual bottom-lines – be it hospitals, pharma, or medical devices – that need to stay agile and find out how to chase the healthcare dollar under evolving coverage frameworks. We are now seeing new care models, such as managed care, once reviled but now rewarded, take root. Even as US reform struggles, this year we expect to see more traction – albeit cautious and gradual – toward right setting care models, and funding and policies of universal coverage across key markets including Indonesia, India, the Philippines, and China.

New Partnerships – Connecting the Dots

Healthcare systems in Asia are disjointed. They are complicated by paper-based systems, privacy laws, and an ecosystem of small, fragmented players. Private partnerships are beginning to plug in the gaps of access to information and influence on the patient. For example, payer + pharma are working together to develop disease management programmes, and providers + healthtech provide remote monitoring tools for chronic patients. These partnerships are also working to shift the balance of power in value capture. Collaborations in online medical commerce in China (for example, idsMED in Hong Kong and WeDoctor – backed by Fung Group in Hong Kong and Tencent) will shake up hospital procurement and the traditional pharma distribution model in what is arguably the world’s most attractive healthcare market. And, on the financing side of the aisle – is there an Asian version of the Amazon-Berkshire-JPMorgan tie-up for employee healthcare on the horizon?

Return of the M&A Hotspots - Bigger and Better 

Private healthcare in Asia was poised to take-off this decade, but last year witnessed a vacuum of deals in traditional large healthcare markets, namely Japan, China, and India. In 2018, we expect a return of investor appetite for three reasons. First, cash-rich conglomerates are increasingly eyeing healthcare as their next venture and seeking opportunities to diversify and leverage their portfolio companies. Second, larger healthcare groups across Asia are hungry for the next phase of growth which will be fuelled by domestic and cross-border acquisitions. Last but not least, as a generation of founder-owners gets ready to cede control, and a new generation of healthtech entrepreneurs emerges, private equity is turning its gaze back to healthcare. The deal hotspots are going to get hotter, not only in major markets, but also in emerging markets like Indonesia, Vietnam and Philippines where unmet needs and economic growth converge, encouraging more investment.

(Finally) Digital Acceleration Across the Ecosystem 

Digital healthcare has had fewer unicorns and more high-profile failures than other disrupted industries. Nevertheless, Asia has more than its fair share of digital players, with US$2.6 billion in investment last year alone. These market shapers are working steadily to tackle Asia’s unmet needs in access, affordability and adherence. And they are generating a lot of noise in the process. The big bets for 2018, however, will be the players that can fix the foundations – enabling data integration, generating data insights, and linking stakeholders together in meaningful ways – and thus rising above the noise of consumer-friendly apps that are soon becoming commoditised, and with limited real commercial value. Governments going digital (Singapore’s National Electronic Health Record, Philippines PhilHealth e-claims and others) will set the stage for a whole host of other solutions (application programme interfaces, data warehouses, forests, and lakes) that enable process efficiencies and information capture across the ecosystem.

This piece originally appeared in Oliver Wyman Health.

Posted on: 07/03/2018 UTC+08:00


Life sciences company OncoSil Medical is to raise A$18.7 million (US$14.4 million) in a two tranche institutional placement and share purchase plan.
Hong Kong listed hospital services company Hua Xia Healthcare has raised HK$46 million (US$5.9 million) in a private placement. Kingston Securities managed the deal.
AK Medical Holdings, which is the largest artificial orthopaedic joint manufacturer in China, has reported a 36.3% rise in profits for the year to Rmb105.4 million (US$16.7 million) on revenues that rose 37.6% to Rmb372.7 million.
Singapore-based DocDoc, a service which enables both locals and medical tourists to find a doctor or dentist across the region, has raised US$5.45 million in Series B funding. The financing is led by Adamas Finance Asia Limited (Adam), a London listed investment company which invested US$2 million via a convertible bond offering alongside regional family offices and high net worth individuals.
The owners of Australian health imaging company Pro Medicus have sold down significant stakes in the company.
IHH Healthcare, Asia’s largest healthcare company, has acquired a 60% stake in Chengdu Shenton Health Clinic, formerly known as Sincere Chengdu Clinic, from Beijing Yizhi Zhuoxin Corporate Management Information for Rmb12 million (US$1.9 million).
Japanese home care nursing group Longlife Holdings plans to set up a fee-based nursing home in Ikeda-shi, Osaka.
Sisram Medical, a Israeli subsidiary of Shanghai Fosun Pharmaceutical, and which manufactures medical aesthetics devices, has reported an 37.2% rise in annual profits to US$11 million on revenues that were up 15.9% to US$136.9 million.


Sumit Sharma, head of health & life sciences, Asia Pacific, at Oliver Wyman, and Matt Zafra, engagement manager, health & life sciences, Oliver Wyman, look at the four themes that are going to dominate healthcare this year.
It can sometimes seem that the healthcare sector is a guaranteed money spinner for investors. It has everything going for it. Societal demands and demographics make it a sure thing, say enthusiasts. And investors have become used to the fact that everything it touches turns to gold.
Yesterday’s stock price fall for Ramsay Health Care was not entirely unexpected. Shares in Australia’s largest private hospital operator dropped 5.75% to A$63.90 (US$49.81) after it revealed distinctly unimpressive first half figures.
Susann Roth, senior social development specialist, Asian Development Bank, gives one way how health risks can be lowered at Special Economic Zones.
Nicole Hill, global director of healthcare at ALE, has a goal to make everyone and everything in healthcare connected. She explains how healthcare is entering a second wave of digitisation in Asia.
There is a simple reason why healthcare stocks on the SGX rose today. Yesterday’s budget was focused firmly on healthcare. Finance minister Heng Swee Keat announced not just an additional S$10.2 billion (US$7.8 million) for healthcare over the next year, he made clear that he was committed to the sector.
A new paper from KPMG looks at the disconnect between consumer expectations and the current healthcare experience of patients in Australia.
Gan Kim Yong, Singapore’s minister for health, explains why integrated care is important in the context of an ageing population.
my images


Hedge Fund Focus

HealthInvestor Asia twitter feed
HIA Indices